Evidence map›Paper›PMID 36504070›Full record

ArticleSurgery today2023

Prophylactic negative pressure wound therapy following colorectal perforation: defining the risk factors for delayed wound healing.

Jun Kawashima, Kota Sahara, Shigeru Yamagishi

Abstract read
PubMed Publisher
In one paragraph

Article in Surgery today, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Observational
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jun KawashimaDepartment of Surgery, Fujisawa City Hospital, 2-6-1 Fujisawa, Fujisawa, Kanagawa, Japan.
Kota SaharaDepartment of Surgery, Fujisawa City Hospital, 2-6-1 Fujisawa, Fujisawa, Kanagawa, Japan.
Shigeru YamagishiDepartment of Surgery, Fujisawa City Hospital, 2-6-1 Fujisawa, Fujisawa, Kanagawa, Japan. gishiyama1225@yahoo.co.jp.
Fujisawa City Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe World Health Organization recommends prophylactic negative pressure wound therapy (NPWT) for high-risk SSI wounds, despite which delayed wound healing (DWH) remains a problem. The aim of this study was to define the risk factors for DWH under prophylactic NPWT following colorectal perforation (CP).

methodsThe subjects of this retrospective study were patients who underwent emergency laparotomy and prophylactic NPWT for CP between 2011 and 2019 at Fujisawa City Hospital in Japan. Multivariable analysis was performed to identify which perioperative factors impact DWH.

resultsA total of 58 patients met the inclusion criteria and the median period from surgery to wound closure was 12 days (IQR: 8-18). Most factors, including preoperative steroid use, diabetes, and serum albumin, were not associated with DWH, although patients requiring catecholamine were more likely to have DWH (OR 7.81, 95% CI 1.55-39.24, p = 0.013). The median in-hospital cost was more than double for patients with DWH vs. those without DWH (41.36 kUSD [IQR 24.95-51.89] vs. 20.32 kUSD [IQR 16.69-28.45], p < 0.001).

conclusionCatecholamine use was a greater risk factor for DWH than previously reported factors such as diabetes and the serum albumin level. Further study is needed to investigate strategies to prevent DWH and optimize the utilization of NPWT, especially in patients requiring catecholamine.

Indexed as

Colorectal NeoplasmsNegative-Pressure Wound TherapyHumansRetrospective StudiesRisk FactorsSurgical Wound InfectionWound HealingColorectal perforationDelayed wound healingNPWT

Identifiers

PMID36504070
OpenAlexW4311074408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.